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Abstract
Background: The systemic inflammatory response syndrome (SIRS) is a complex immune response which can be 
precipitated by non-infectious aetiologies such as trauma, burns or pancreatitis. Addressing the underlying cause is 
crucial because it can be associated with increased mortality. Although the current literature associates chronic heart 
failure with SIRS, acute right ventricular dysfunction has not previously been reported to trigger SIRS. This case report 
describes the presentation of acute right ventricular dysfunction that triggered SIRS and mimicked septic shock. 
Case presentation: A 70-year-old male presented to the Intensive Care Unit (ICU) with elevated inflammatory mark-
ers and refractory hypotension after a robotic-assisted laparoscopic radical choledochectomy with pancreaticoduo-
denectomy. Septic shock was misdiagnosed, and he was later found to have a pulmonary embolus. Thrombectomy 
and antimicrobials had no significant effect on lowering the elevated inflammatory markers or improving the per-
sistent hypotension. Through Point of Care Ultrasound (POCUS), right ventricular dysfunction was diagnosed. Treat-
ment with intravenous milrinone improved blood pressure, normalised inflammatory markers and led to a prompt 
discharge from the ICU.
Conclusion: Acute right ventricular dysfunction can trigger SIRS, which may mimic septic shock and delay appropriate 
treatment. 
Keywords: Point of Care Ultrasound (POCUS), acute right ventricular failure, acute right ventricular dysfunction, sys-
temic inflammatory response syndrome, septic shock, sepsis
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 Introduction
The Systemic Inflammatory Response Syndrome 
(SIRS) was first defined by Bone et al. (1992) [1] which 
describes widespread inflammation within the human 
body caused by a complex immune response to an in-
sult [1,2]. It is characterized by the presence of two or 
more of the following features: (i) temperature >38°C 
or <36°C, (ii) heart rate >90 beats/minute, (iii) respira-
tory rate >20/min or PaCO2 <32mmHg (4.3 kPa) (iv) 
white blood cell count >12 000/mm3 or <4000/mm3 
or >10% immature bands. Although SIRS was initially 
thought to be within the spectrum of sepsis [3], other 
precipitants of SIRS have since been acknowledged. 
Non-infectious causes of SIRS include, but are not 
limited to, pancreatitis, trauma, haemorrhage, burns, 
chronic heart failure, pulmonary embolism and ana-
phylaxis [4-7]. Due to this non-specificity of SIRS in 
discriminating infection from other non-infectious 
causes, the definition of sepsis has since been revised to 
improve its management in clinical practice.
Recently, the 3rd International Consensus Defini-
tions for Sepsis and Septic Shock proposed new defini-
tions for sepsis and septic shock to make it more distin-
guishable from SIRS. Concerns with the sensitivity of 
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the previous definition of sepsis were raised since one 
in eight patients admitted to critical care units with in-
fection, and recent organ failure failed to meet the cri-
teria of SIRS to fulfil the definition of sepsis, but never 
the less experienced significant morbidity and mortal-
ity [3,8]. As a result, the new definition for sepsis is now 
stated as “a life-threatening organ dysfunction caused 
by a dysregulated host response to infection”, character-
ised by “an acute change of the sequential organ failure 
assessment (SOFA) score ≥ 2 due to infection” [3]. For 
septic shock, the proposed Sepsis-3 criteria are “sepsis 
with persisting hypotension requiring vasopressors to 
maintain mean arterial pressure (MAP) ≥ 65mmHg 
and having a serum lactate level ≥ 2 mmol/L (18mg/
dL) despite adequate fluid resuscitation [3].” However, 
even with these changes in definitions, clinicians must 
be aware that the SIRS response is still valid beyond 
sepsis and remain vigilant for the non-infectious caus-
es that trigger it (Figure 1 summarises the relationship 
between infection, organ dysfunction, SIRS, sepsis and 
septic shock taking these revised definitions into ac-
count).
The triggering of SIRS by acute isolated right ven-
tricular (RV) dysfunction has not been previously re-
ported. Here, we describe a case of acute RV dysfunc-
tion, which through SIRS response and multi-organ 
failure, mimicked the presentation of septic shock. It 
was only through point of care ultrasound (POCUS) 
that the correct diagnosis was made and appropriate 
treatment was administered successfully.
 Case Description
A 70-year-old male first presented at the accident and 
emergency department of a general district hospi-
tal in Malacca, Malaysia, with a three-month history 
of painless jaundice. He also had a history of hyper-
tension and morbid obesity with a body mass index 
(BMI) of 35kg/m2.
Magnetic resonance imaging (MRI) revealed a 
1.6cm mass in the common bile duct suggestive of a 
cholangiocarcinoma. Endoscopic retrograde cholan-
giopancreatography (ERCP) was performed, and a bil-
Fig. 1. Relationships between infection, organ dysfunction, sepsis, septic shock and SIRS taking into account revised 
definitions by Sepsis-3
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iary stent was placed on the second day of admission 
to hospital as a temporary measure. The patient was 
discharged home the following day. 
One month after his initial presentation, the patient 
sought further treatment in Singapore. He subsequent-
ly underwent a robotic-assisted laparoscopic radical 
choledochectomy and pancreaticoduodenectomy at 
the Singapore General Hospital. A laparoscopic ap-
proach was chosen to facilitate faster recovery and 
early mobilisation. 
Due to the concern of bleeding following surgery, 
prophylactic anti-coagulation was omitted. Instead, the 
surgeon-in–charge opted for thrombo-embolic-deter-
rent (TED) compression stockings and pneumatic calf 
compressors, which were utilised intra-operatively to 
minimise the risk of deep vein thrombosis. A two-gram 
single dose of ceftriaxone (PT Indofarma, Palembang, 
Indonesia) and metronidazole 500mg (Baxter, Deer-
field, Illinois, USA) was administered intravenously 
as surgical antibiotic prophylaxis. The patient’s obese 
body habitus and difficult surgical access prolonged the 
duration of the operation, which lasted thirteen hours. 
Postoperatively, the patient was extubated and trans-
ferred to the surgical high dependency unit (SHDU) 
for monitoring since he was haemodynamically stable. 
On the first postoperative day, the patient developed 
acute kidney injury as indicated by a “kidney disease 
improving global outcome” (KDIGO) score of 2, and 
by oliguria, the urine output being <0.5ml/kg/hour 
over six hours. The serum creatinine levels rose from 
97 to 235 µmmol/L. He was also mildly febrile with a 
temperature of 37.5 oC and tachycardic with a heart rate 
of 110 beats/min. His blood pressure ranged between 
91/59 mmHg to 116/72 mmHg. There was no overt 
blood loss or bilious fluid from the surgical drains. 
Based on the clinical parameters of oliguria, tachy-
cardia and borderline blood pressure suggesting a 
hypovolemic state, the on call surgeons in the SHDU 
administered fluid boluses totalling two litres. This did 
not result in any clinical improvement. Subsequently, 
the patient had an episode of desaturation to 91% as 
measured on pulse oximetry. He was mildly tachyp-
noeic with a respiratory rate of 18 to 20 breaths per 
minute. The patient’s obese body habitus limited physi-
cal examination, and it was clinically challenging to 
discern if the patient was euvolemic or hypervolemic. 
Chest auscultation revealed soft bilateral crepitations in 
the lung bases, but a chest X-Ray (CXR) demonstrated 
only basal atelectasis. Given the positive fluid balance, 
bibasal crepitations, oliguria and rising creatinine lev-
els, a provisional diagnosis of fluid overload and acute 
kidney injury was made. 80mg of intravenous furo-
semide (Pfizer Ltd, Lake Forest, Illinois, USA) was 
given to facilitate diuresis, but no significant effect was 
observed. 
On the second postoperative day, while awaiting re-
nal replacement therapy, he developed transient supra-
ventricular tachycardia (SVT). His heart rate was 180 
beats/min and BP was 80/40 mmHg. The SVT reverted 
spontaneously to sinus tachycardia with a heart rate of 
100-110 beats per minute and his blood pressure sub-
sequently normalised. Oral bisoprolol (Sandoz, Cam-
berley, UK) 1.25mg was started. However, a few hours 
later, the SVT recurred to 160-170 beats/min, and the 
BP decreased to 70/40 mmHg. 
A single synchronised direct current shock of 50 
Joules was administered which successfully converted 
the SVT to sinus rhythm and improved systolic blood 
pressure to 90-100mmHg. 
At this point, he was then admitted to the ICU for 
closer monitoring. Laboratory tests showed raised in-
flammatory markers; procalcitonin (PCT) 48µg/L, 
C-Reactive protein (CRP) 278mg/L and white cell 
count 3.96 x 109/L. Arterial blood gas analysis demon-
strated a high anion gap metabolic acidosis (pH 7.21, 
BE-11, HCO3 15mmol/L and lactate 4.3mmol/L). The 
laboratory blood chemistry results were as follows: 
urea 11.1mmol/L, creatinine 235 µmmol/L, sodium 
139mmol/L, potassium 4.2mmol/L and magnesium 
0.99mmol/L. 
A 12-lead Electrocardiogram (ECG), apart from si-
nus tachycardia post-cardioversion, did not reveal any 
ST changes and serial Troponin T levels were normal.
In the ICU, he had increasing oxygen requirements 
and was intubated by the ICU registrar on call, one 
hour after ICU admission. On controlled mechanical 
ventilation with a fractional inspired oxygen concen-
tration (FiO2) of 0.8, the initial PaO2 was 69.9mmHg 
and PaCO2 38 mmHg. 
Given a positive culture of Enterococcus faecalis from 
his biliary stent taken intra-operatively, together with 
the clinical presentation and investigations, a presump-
tive diagnosis of septic shock from intra-abdominal 
sepsis was made. Obstructive and cardiogenic shock 
were less likely to occur, given that there was no pneu-
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mothorax detected on CXR, and serial ECGs together 
with troponin T levels were within the normal range.
Blood cultures were performed within an hour after 
ICU admission. Empirical broad-spectrum, intrave-
nous antibiotics comprising tigecycline 50mg (Pfizer 
Ltd, Lake Forest, Illinois, USA) 12 hourly, meropenem 
2g (Pfizer Ltd, Lake Forest, Illinois, USA) 8 hourly and 
anidulafungin 100mg (Merck Sharp & Dohme Ltd, 
Madrid, Spain) daily were started immediately after-
wards.
Intravenous noradrenaline (Pfizer Ltd Lake Forest, 
Illinois, USA) 0.2µg/kg/min was required to maintain 
a mean arterial pressure above 65mmHg. However, his 
noradrenaline requirements began to rise soon after, 
and a repeat arterial blood gas analysis showed that the 
serum lactate had increased to 8.0 mmol/L. PCT re-
mained elevated at 35 µg/L, and CRP rose to 334mg/L. 
Continuous renal replacement therapy was also initi-
ated, given the acute kidney injury and haemodynamic 
instability.  
Due to persistent hypotension together with esca-
lating inotrope and vasopressor requirements of no-
radrenaline (Pfizer Ltd, Lake Forest, Illinois, USA) 
0.3µg/kg/min and vasopressin (Pfizer Ltd, Lake Forest, 
Illinois, USA) 0.03U/min, a point of care ultrasound 
(POCUS) and bedside echocardiography was per-
formed two hours after ICU admission. 
Ultrasonography of the chest and abdomen ruled 
out free fluid within the lungs and abdomen. Due to 
the patient’s obese habitus and overlying bowel gas, the 
aorta could not be visualised. Bedside echocardiog-
raphy showed preserved left ventricular performance 
but exhibited severe right ventricular enlargement and 
systolic dysfunction with akinesia of the mid-ventric-
ular segments but preserved contractility of the apex 
(McConnell sign). The inferior vena cava was partially 
visualized and noted to be plethoric on inspiration.
The RV was also dilated with a flattened septum, 
suggesting a “pressure overload” state (Figure 2). The 
left ventricular appeared normal. A CT pulmonary 
angiogram was performed within a few hours of the 
initial echocardiography assessment, which confirmed 
the diagnosis of a pulmonary embolism (PE) involving 
the right pulmonary artery (Figure 3). A CT scan of the 
abdomen and pelvis was done concurrently because of 
the limited views obtained by POCUS. This did not re-
veal any significant intra-abdominal free fluid or source 
of infection, and the initial diagnosis was then revised 
to “an acute RV dysfunction secondary to pulmonary 
embolism.” 
Heparin (Baxter, Deerfield, Illinois, USA) infusion 
was started and titrated to maintain the partial throm-
boplastin time (PTT) of about 60 seconds.  An inter-
 
Fig. 2. Bedside echocardiography demonstrated dilated 
RV with flattened interventricular septum (white arrow) 
due to pulmonary embolism. Quality of the image was 
limited by patient's body habitus
Fig. 3. CT Pulmonary Angiography demonstrated a filling 
defect in the right pulmonary artery (white arrow) indicat-
ing the presence of a pulmonary embolism
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ventional radiologist performed a percutaneous pul-
monary thrombectomy. Complete embolus removal 
was achieved, resulting in the restoration of normal 
blood flow in the right pulmonary artery. 
However, the patient’s haemodynamic parameters 
and inflammatory markers continued to worsen. On 
the third postoperative day (ICU Day 2), bedside echo-
cardiography demonstrated no improvement of the 
acute RV dysfunction despite complete clearance of the 
thrombus in the right pulmonary artery. This elucidat-
ed severe RV dysfunction as the cause of persistent hy-
potension. Left ventricular function remained normal. 
There were no significant valvular abnormalities. The 
diagnosis of SIRS secondary to RV dysfunction was 
suspected, and an intravenous milrinone (Pfizer Ltd, 
Lake Forest, Illinois, USA) infusion was started and 
titrated to a maximum dose of 0.5mcg/kg/min. Clini-
cal recovery was noted a few hours later as the blood 
pressure was maintained above systolic 100mHg with 
reducing doses of vasoactive agents. The patient also 
started to diurese spontaneously from being anuric 
upon ICU admission. 
On the fourth postoperative day (ICU Day 3), the 
noradrenaline and vasopressin infusions were ceased 
seventeen hours after milrinone (Pfizer Ltd, Lake For-
est, Illinois, USA) was started.
Laboratory tests performed twelve hours later also 
showed that the inflammatory markers were normalis-
ing, the base deficit had improved from -11.4 to -2.4 
and lactate levels fell from 8.0 to 2.1mmol/L. 
Another repeat bedside echocardiography, per-
formed on ICU day three, demonstrated a significant 
improvement in right ventricular contractility. Oxygen 
requirements were also reduced with Fi02 from 0.8 to 
0.4. There was improved oxygenation with the arte-
rial blood gas PaO2 returning from 69mmHg to 131 
mmHg.  These responses to milrinone did not support 
the hypothesis that surgical trauma or infection was the 
cause of SIRS.  Extubation and complete normalisation 
of PCT and CRP levels were achieved in the next for-
ty-eight hours. The anti-microbials were stopped one 
week later when blood cultures, urine cultures and re-
peat CXR yielded no indication of infection. 
The patient continued to make progress and was 
soon transferred to a step-down ward.  
 Discussion
This patient had multi-organ dysfunction with an acute 
rise in SOFA score from 0 to 7. His raised inflammatory 
markers and positive biliary stent culture, together with 
hemodynamic instability requiring inotropic support, 
fulfilled both definitions of sepsis and septic shock as 
defined in Sepsis-3. The combination of these factors 
led to his initial misdiagnosis of septic shock.
Acute right ventricular dysfunction was not sus-
pected as a cause of his pro-inflammatory state because 
an association with SIRS had not been previously re-
ported. However, given that no source of infection 
was found after repeated fluid cultures and imaging, it 
was concluded that the grossly elevated inflammatory 
markers were due to a SIRS response.  
It was then hypothesised that the trigger of SIRS, in 
this patient, was RV dysfunction and not PE because 
no improvement was observed after treatment with 
heparin and the restoration of normal flow within the 
pulmonary artery after thrombectomy. On the con-
trary, the patient continued to deteriorate despite the 
treatment for PE. A dramatic clinical recovery and rap-
id improvement of inflammatory markers were only 
noted after the treatment of acute RV dysfunction with 
milrinone. 
Hasper et al. (1998) [5] had earlier reported that the 
signs of systemic inflammation and SIRS-associated 
cytokines were elevated in patients with chronic heart 
failure, but interestingly both disappeared after patients 
were provided mechanical circulatory support. Our 
patient also had normal serial troponins and ECGs, 
which does not support myocardial infarction-induced 
cardiogenic shock and SIRS, and sepsis-related myo-
cardial dysfunction [9-10]. Cardiogenic shock mainly 
arises from left ventricular dysfunction and rarely from 
right ventricular function [11]. Milrinone, as a bipy-
ridine phosphodiesterase (PDE)-3 inhibitor, improves 
RV contractility and reduces pulmonary vascular re-
sistance (PVR) by vasodilation. This reversed the acute 
RV dysfunction, which led to the resolution of SIRS 
and recovery of the patient.
This important observation of SIRS caused by acute 
RV dysfunction suggests clinicians must be vigilant for 
RV dysfunction mimicking or masked by septic shock 
because the treatment of both conditions can be antag-
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onistic, e.g. intravenous fluid given for sepsis can exac-
erbate right ventricular dysfunction. RV failure is clini-
cally recognised as an acute RV dysfunction resulting in 
a low cardiac output state with hypoperfusion of major 
organs [12]. The classical physical findings, including 
ECG changes, may not always be present [13]. In acute 
RV pressure overload state, end-systolic flattening of 
the interventricular septum due to interventricular in-
terdependence is usually an early sign. Sustained high 
RV afterload may lead to acute RV stunning, resulting 
in reduced contractility. This may progress to an RV 
volume overload state with tricuspid regurgitation and 
global RV enlargement [14]. 
Progressive venous congestion from RV dysfunction 
leads to impairment of renal, hepatic and intestinal 
function, resulting in increased morbidity and mortal-
ity [15]. Therefore, the elevated inflammatory markers 
in our patient could also be due to the presence of he-
patic and splenic congestion in right ventricular (RV) 
failure. Polsinelli et al (2017) and Sandek et al (2008) 
in reviewing RV-gut interactions in patients with heart 
failure, proposed that visceral venous congestion could 
result in hypoxia and acidosis in enterocytes, altera-
tion of the gut microbiome leading to increased gut 
permeability and inflammation and alteration of renal 
haemodynamics with triggering of the cardiorenal syn-
drome [15,16]. Hence, effective management of acute 
RV dysfunction requires accurate assessment of RV 
preload, contractility and afterload.
Classically, patients with RV failure are preload-de-
pendent [17]. However, over aggressive volume loading 
has the potential to over distend the RV and worsen 
wall tension and contractility [15]. Volume status must, 
therefore, be carefully evaluated, as both hypovolemia 
and hypervolemia can lead to a further decrease in 
cardiac output. In right heart dysfunction, the ideal 
vasoactive agent of choice is one that can reduce RV af-
terload, increase RV contractility while preserving RV 
perfusion pressure [13]. Inodilators like milrinone and 
levosimendan have been used widely for the treatment 
of RV failure [13],[17]. Due to its vasodilatory proper-
ties, milrinone is often used in conjunction with a va-
sopressor. 
It is clinically challenging to differentiate between 
sepsis and its mimickers. Studies on proteins and cy-
tokines related to the host response to infection have 
no definitive conclusion on how to distinguish inflam-
mation from sepsis using biomarkers such as CRP, In-
terleukin 6 and 8, soluble TREM1 and PLAUR[18-20].
A recent systematic review and meta-analysis by 
Tan et al. (2019) looking at the diagnostic accuracy of 
both PCT and CRP concluded that PCT was a better 
diagnostic tool for sepsis [21]. Their data gave an AU-
ROC score CRP: 0.73 (95% CI 0.69 - 0.77) vs AUROC 
score PCT: 0.85 (95% CI 0.82 - 0.88). However, both 
biomarkers were found to have moderate specificity 
with wide confidence intervals.  Interestingly, recent 
advancements in biotechnology have facilitated DNA-
based molecular techniques which produce rapid mi-
crobial identification and antimicrobial susceptibility 
with high sensitivity and specificity. This may prove to 
be another tool in the armamentarium for differentiat-
ing between sepsis and sepsis mimickers [22]. 
In our experience, POCUS utilising the Rapid Ultra-
sound in Shock (RUSH) protocol is another useful tool 
in differentiating the different types of shock in both 
emergency departments and critical care units [23-25]. 
Table 1 summarises the salient ultrasonographic fea-
tures of the different types of shock. A meta-analysis of 
the diagnostic accuracy of using the RUSH protocol in 
the emergency department by Keikha et al. (2018) re-
ported a higher sensitivity and specificity in diagnosing 
hypovolemic, cardiogenic and obstructive shock but 
lower sensitivity for shock with distributive or mixed 
aetiology [26]. Despite its limitations, there is growing 
popularity for the use of POCUS in the intensive care 
setting. Being portable and non-invasive, POCUS pro-
vides physicians with useful information for the ma-
jority of critically ill patients, especially in those whom 
heart failure, valvular heart disease, hypovolaemia and 
hypervolemia are suspected [27]. In our opinion, PO-
CUS is an extremely useful and consideration should 
be made to incorporate it into intensive care training. 
 Conclusion
Despite recent revisions to the definition of sepsis and 
septic shock, clinicians should be aware that SIRS re-
mains a clinical problem that can be precipitated by 
non-infectious aetiologies. Acute RV dysfunction can 
trigger a SIRS response that mimics sepsis, and septic 
shock if the RV dysfunction is severe. 
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Table 1. Bedside Point of Care Ultrasound (POCUS) examination findings by systems to evaluate the aetiology of shock
SYSTEMS
SHOCK
Hypovolemic Shock Cardiogenic Shock Distributive Shock Obstructive Shock
Cardiovascular
Findings
Hypercontractile 
heart with small Left 
Ventricle chamber 
size
Hypocontractile 
heart with dilated 
Left Ventricle
Hypercontractile heart in 
early sepsis
Hypocontractile heart in late 
sepsis
Cardiac Tamponade 
- Presence of pericardial 
fluid
- Right ventricle collapse 
during diastole
Presence of Cardiac 
Thrombus
Right Ventricle Dysfunc-
tion (Pulmonary Embo-
lism)
- Hypocontractile RV 
with dilatation
- Moderate to severe 
tricuspid regurgitation
- McConnell’s sign (re-
duced right ventricular 
free wall motion but 
reserved apical motion)
- D shaped ventricle 
with abnormal motion in 
interventricular septum
Respiratory
Findings
Hemothorax
- Presence of ho-
mogeneous echoic 
effusion/Hematocrit 
Sign
Pulmonary edema
- Lung rockets with 
multiple diffuse B 
lines 
Pleural Effusion
- Presence of free 
pleural fluid
Pneumonia
- Presence of Air broncho-
gram 
- Loss of A lines, 
- Presence of patchy B lines
- Pleural effusion with/with-
out multiple septations
Tension Pneumothorax
- Absence of normal lung 
sliding
- Absence of seashore 
sign on M  mode
- Presence of barcode 
sign on M mode
Abdominal 
and Other 
Findings
Collapsed Inferior 
Vena Cava   
(< l2mm)
Ruptured/Leaking 
Abdominal Aortic 
Aneursym
- Focal aortic dilata-
tion 
- Peri-aortic fluid, 
free intraperitoneal 
fluid, retroperitoneal 
fluid
Aortic dissection 
- Presence of aortic 
root dilatation and 
intimal flap on the 
Parasternal Long Axis 
or longitudinal views 
(transthoracic or 
transabdominal)
Distended  Inferior 
Vena Cava
(> 20mm)
Collapsed  Inferior Vena Cava  
(<12mm)
Peritonitis
- Presence of peritoneal fluid 
with/without septation
Pyelonephritis
- Swollen kidney with in-
creased anechoic corticome-
dullary area
Cholecystitis
- Presence of cholelithiasis
- Sonographic Murphy sign 
- Gallbladder wall thicken-
ing (>3mm) and presence of 
pericholecystic fluid
Cholangitis
- Common bile duct dilata-
tion 
- Thickening of wall of bile 
ducts
- Presence of debris in the 
common bile ducts (pus or 
sludge)
Distended  Inferior Vena 
Cava  (> 20mm)
Presence of Lower Limb 
Deep Vein Thrombosis
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